A randomised phase II study of gemcitabine/cisplatin alone and with herceptin in patients with HER2-positive non-small cell lung cancer (nsclc)
- 30 April 2001
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 37, S50
- https://doi.org/10.1016/s0959-8049(01)80665-1
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: